Evidence map›Paper›PMID 36971473›Full record

ArticleIUBMB life2023

Protein Tyrosine Phosphatases: Mighty oaks from little acorns grow.

Nicholas K Tonks

Abstract read
In one paragraph

Article in IUBMB life, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nicholas K TonksCold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.ORCID 0000-0002-2394-1538

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI David A Tuveson · 1987 to 2026
$118.9M
PROTEIN TYROSINE DEPHOSPHORYLATION &SIGNAL TRANSDUCTIONR01CA053840 · NCI · COLD SPRING HARBOR LABORATORY · PI TONKS, NICHOLAS K · 1991 to 2025
$11.8M
Protein Tyrosine Dephosphorylation &signal TransductionR37CA053840 · NCI · COLD SPRING HARBOR LABORATORY · PI TONKS, NICHOLAS K · 2001 to 2008
$5.2M
Receptor PTPs, Cell Contact and Signal TransductionR01DK124907 · NIDDK · COLD SPRING HARBOR LABORATORY · PI TONKS, NICHOLAS K · 2020 to 2023
$1.9M
NCI NIH HHS P30 CA045508NCI NIH HHS R01 CA053840NCI NIH HHS R37 CA053840NIDDK NIH HHS R01 DK124907NIH HHS CA045508NIH HHS CA053840NIH HHS DK124907
6 · The paper itself

Abstract

In October 2020, we were finally able to gather for a celebration of Eddy Fischer's 100th birthday. As with many other events, COVID had disrupted and restricted preparations for the gathering, which ultimately was held via ZOOM. Nevertheless, it was a wonderful opportunity to share a day with Eddy, an exceptional scientist and true renaissance man, and to appreciate his stellar contributions to science. Eddy Fischer, together with Ed Krebs, was responsible for the discovery of reversible protein phosphorylation, which launched the entire field of signal transduction. The importance of this seminal work is now being felt throughout the biotechnology industry with the development of drugs that target protein kinases, which have transformed the treatment of a wide array of cancers. I was privileged to have worked with Eddy both as a postdoc and a junior faculty member, during which time we laid the foundations for our current understanding of the protein tyrosine phosphatase (PTP) family of enzymes and their importance as critical regulators of signal transduction. This tribute to Eddy is based upon the talk I presented at the event, giving a personal perspective on Eddy's influence on my career, our early research efforts together in this area, and how the field has developed since then.

Indexed as

COVID-19QuercusHumansPhosphorylationProtein Tyrosine PhosphatasesSignal TransductionProtein Tyrosine PhosphatasesDrug discoveryProtein KinaseProtein Tyrosine Phosphatasesignal transduction

Identifiers

PMID36971473
PMCPMC10254075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.